Search results for:
talimogene laherparepvec
talimogene laherparepvec
Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
Talimogene Laherparepvec |
SUSPENSION, INJECTABLE |
1 mpfu/mL (1 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Talimogene Laherparepvec |
SUSPENSION, INJECTABLE |
100 mpfu/mL (1 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Apr. 19, 2023
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of talimogene laherparepvec injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Med Center
UNC Medical Center Formulary Restrictions